--- title: "Asian Value Stock Picks For Intrinsic Valuation Estimates January 2026" type: "News" locale: "en" url: "https://longbridge.com/en/news/272024624.md" description: "As of January 2026, Asian markets are facing mixed performances, particularly in China and Japan. Investors are focusing on undervalued stocks based on intrinsic valuation estimates. Notable picks include Zhejiang Century Huatong Group, Xiamen Amoytop Biotech, and WuXi XDC Cayman, all showing significant discounts to their fair values. Morimatsu International Holdings and Tianqi Lithium are highlighted for their growth potential despite recent challenges. The article emphasizes the importance of thorough analysis and offers insights into various undervalued stocks in the Asian market." datetime: "2026-01-09T05:00:40.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/272024624.md) - [en](https://longbridge.com/en/news/272024624.md) - [zh-HK](https://longbridge.com/zh-HK/news/272024624.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/272024624.md) | [繁體中文](https://longbridge.com/zh-HK/news/272024624.md) # Asian Value Stock Picks For Intrinsic Valuation Estimates January 2026 As we enter 2026, Asian markets are navigating a complex landscape marked by mixed performances in major economies like China and Japan, with slight gains in manufacturing and technology sectors amid ongoing economic uncertainties. In this environment, identifying undervalued stocks requires a keen focus on intrinsic valuation estimates, as investors seek opportunities that offer potential value amidst fluctuating market conditions. ### Top 10 Undervalued Stocks Based On Cash Flows In Asia **Name** **Current Price** **Fair Value (Est)** **Discount (Est)** Zhejiang Century Huatong GroupLtd (SZSE:002602) CN¥19.06 CN¥37.98 49.8% Xiamen Amoytop Biotech (SHSE:688278) CN¥82.07 CN¥161.67 49.2% WuXi XDC Cayman (SEHK:2268) HK$68.40 HK$135.71 49.6% PeptiDream (TSE:4587) ¥1747.00 ¥3449.68 49.4% Mobvista (SEHK:1860) HK$15.44 HK$30.63 49.6% Meitu (SEHK:1357) HK$7.42 HK$14.63 49.3% CURVES HOLDINGS (TSE:7085) ¥792.00 ¥1577.34 49.8% Contec.Co.Ltd (KOSDAQ:A451760) ₩14490.00 ₩28785.36 49.7% ASE Technology Holding (TWSE:3711) NT$273.50 NT$538.87 49.2% Aidma Holdings (TSE:7373) ¥3160.00 ¥6305.80 49.9% Click here to see the full list of 259 stocks from our Undervalued Asian Stocks Based On Cash Flows screener. Here's a peek at a few of the choices from the screener. ## Morimatsu International Holdings (SEHK:2155) **Overview:** Morimatsu International Holdings Company Limited is involved in the design, manufacture, installation, operation, and maintenance of core equipment and process systems for chemical reactions, biological reactions, and polymerization with a market cap of HK$12.83 billion. **Operations:** The company generates revenue primarily from the sale of comprehensive pressure equipment, amounting to CN¥6.16 billion. **Estimated Discount To Fair Value:** 48.6% Morimatsu International Holdings appears undervalued, trading at HK$10.3 against an estimated fair value of HK$20.05, suggesting it is 48.6% below fair value based on discounted cash flow analysis. Despite significant insider selling recently and the unfortunate passing of a key board member affecting compliance with listing rules, the company shows strong potential with earnings expected to grow significantly at 23% annually, outpacing Hong Kong's market average growth rate of 12%. - In light of our recent growth report, it seems possible that Morimatsu International Holdings' financial performance will exceed current levels. - Unlock comprehensive insights into our analysis of Morimatsu International Holdings stock in this financial health report. SEHK:2155 Discounted Cash Flow as at Jan 2026 ## Tianqi Lithium (SZSE:002466) **Overview:** Tianqi Lithium Corporation engages in the investment, production, processing, extraction, and sale of lithium and lithium compounds across Australia, Chile, and China with a market cap of CN¥94.40 billion. **Operations:** Tianqi Lithium generates revenue primarily from the production and sale of lithium, lithium concentrate, and specialty lithium compounds in Australia, Chile, and China. **Estimated Discount To Fair Value:** 42.8% Tianqi Lithium is trading at CN¥58.62, significantly below its estimated fair value of CN¥102.5, highlighting a substantial undervaluation based on discounted cash flow analysis. Despite recent executive changes and volatile share prices, the company reported a net income turnaround for the nine months ending September 2025 and is expected to achieve profitability within three years. Revenue growth is projected to exceed China's market average, enhancing its appeal as an undervalued investment opportunity in Asia. - Insights from our recent growth report point to a promising forecast for Tianqi Lithium's business outlook. - Take a closer look at Tianqi Lithium's balance sheet health here in our report. SZSE:002466 Discounted Cash Flow as at Jan 2026 ## Innodisk (TPEX:5289) **Overview:** Innodisk Corporation is engaged in the research, development, manufacturing, and sale of industrial embedded storage devices across various international markets with a market cap of NT$61.50 billion. **Operations:** The company generates revenue of NT$11.68 billion from its segment focused on the research and development of various industrial memory storage devices. **Estimated Discount To Fair Value:** 22.5% Innodisk, trading at NT$645, is valued below its estimated fair value of NT$832.02, indicating a significant undervaluation based on cash flow analysis. The company reported strong earnings growth for the third quarter of 2025, with net income reaching NT$643.04 million compared to NT$188.62 million a year ago. Recent product advancements in AI technology through collaboration with Qualcomm enhance Innodisk's market position and potential for revenue growth exceeding Taiwan's market average. - Our comprehensive growth report raises the possibility that Innodisk is poised for substantial financial growth. - Click here to discover the nuances of Innodisk with our detailed financial health report. TPEX:5289 Discounted Cash Flow as at Jan 2026 ## Next Steps - Navigate through the entire inventory of 259 Undervalued Asian Stocks Based On Cash Flows here. - Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports. - Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world. ## Searching for a Fresh Perspective? - Explore high-performing small cap companies that haven't yet garnered significant analyst attention. - Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. - Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. _This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation.** We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._ ### Related Stocks - [AMOYTOP (688278.CN)](https://longbridge.com/en/quote/688278.CN.md) - [TLC (002466.CN)](https://longbridge.com/en/quote/002466.CN.md) - [TIANQI LITHIUM (09696.HK)](https://longbridge.com/en/quote/09696.HK.md) ## Related News & Research - [Ganfeng Lithium Shareholders Approve All Resolutions at 2026 Extraordinary Meeting](https://longbridge.com/en/news/278737752.md) - [Tianqi Lithium Books 119% Higher Profit in Q3](https://longbridge.com/en/news/263429089.md) - [Haohai Biological Sets March 2026 Board Meeting to Review 2025 Results and Dividend Plan](https://longbridge.com/en/news/278518857.md) - [Jiangsu Recbio Schedules March 2026 Board Meeting on 2025 Results and Dividend](https://longbridge.com/en/news/278861880.md) - [BREAKINGVIEWS-War will test Asia stock rally resilience pitch](https://longbridge.com/en/news/278657791.md)